Device Trial Radar · NCT05599308
Evaluation of Blood Pressure Monitor With AFib Screening Feature
Last checked: Nov 19, 2026Latest source record: Apr 28, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
574
Actual
Start
Sep 6, 2022
Primary completion
Apr 11, 2023
Study completion Apr 11, 2023
Sponsor
- Lead sponsor
- Omron Healthcare Co., Ltd.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- ICON plc
- First posted
- Oct 31, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Screening
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study aims to evaluate the safety and effectiveness of the Omron blood pressure (BP) monitor with AFib screening feature. The primary outcome is to validate if the Omron BP-monitor with AFib screening feature meets acceptance criteria in sensitivity and specificity. The acceptance criteria of the sensitivity and specificity should be statistically non-inferior to those of primary predicate device.
Conditions
- Atrial Fibrillation
Interventions
OMRON blood pressure monitor with AFib screening featureDevice
Blood pressure measurement by an oscillometric blood pressure monitor
Microlife WatchBP Home ADevice
Blood pressure measurement by an oscillometric blood pressure monitor
Primary outcomes
What the sponsor says the trial is designed to measure.
- SensitivityTime frame: 1 day
- SpecificityTime frame: 1 day
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Accelacare of DuPage Medical Group
Winfield, Illinois
Accelacare of MacFarland Clinic
Ames, Iowa
Accelacare of Charlotte
Charlotte, North Carolina
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.